SCHEMBL2180608

SCHEMBL2180608

Cn1c(=O)cc(N(CCO)N=Cc2ccc(Cl)c(Cl)c2)[nH]c1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
HPGD P15428 2/20 0.62
NR1I2 O75469 1/20 0.62
AHR P35869 1/20 0.62
LMNA P02545 3/20 0.55
PKM P14618 2/20 0.55
KDM4E B2RXH2 4/20 0.47
KDM4C Q9H3R0 2/20 0.47
THRB P10828 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.40
GAA P10253 4/20 0.39
KMT2A Q03164 5/20 0.37
MEN1 O00255 4/20 0.37
CASP1 P29466 1/20 0.37
BRCA1 P38398 1/20 0.37
CASP7 P55210 1/20 0.37
HSD17B10 Q99714 1/20 0.37
G6PC1 P35575 1/20 0.36
MAPT P10636 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180606 1.00 ALDH1A1 (0.62) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2179902 0.89 ALDH1A1 (0.78) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2179900 0.89 ALDH1A1 (0.78) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2182166 0.86 ALDH1A1 (0.62) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2182167 0.86 ALDH1A1 (0.62) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2182041 0.84 ALDH1A1 (0.60) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2182037 0.84 ALDH1A1 (0.60) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2179033 0.83 KDM4E (0.70) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2179029 0.83 KDM4E (0.70) ALDH1A1HPGDNR1I2AHRLMNA
SCHEMBL2182930 0.83 ALDH1A1 (0.59) ALDH1A1HPGDNR1I2AHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed
WO-2010014798-A2 PYRIMIDOTRIAZINEDIONES AND PYRIMIDOPYRIMIDINEDIONES AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR ALDH1A1 245/4885HPGD 237/4885NR1I2 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.